ID: ALA217674

Max Phase: Preclinical

Molecular Formula: C18H24O4

Molecular Weight: 304.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)c1cc2c(cc1O)C[C@@]1(O2)[C@@H](C)CC[C@@H](O)C1(C)C

Standard InChI:  InChI=1S/C18H24O4/c1-10-5-6-16(21)17(3,4)18(10)9-12-7-14(20)13(11(2)19)8-15(12)22-18/h7-8,10,16,20-21H,5-6,9H2,1-4H3/t10-,16+,18+/m0/s1

Standard InChI Key:  RYEIGWLPNHBHCW-FEMPBKKVSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 304.39Molecular Weight (Monoisotopic): 304.1675AlogP: 3.09#Rotatable Bonds: 1
Polar Surface Area: 66.76Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.56CX Basic pKa: CX LogP: 3.36CX LogD: 3.36
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.78Np Likeness Score: 2.30

References

1. Useglio M, Castellano PM, Operto MA, Torres R, Kaufman TS..  (2006)  Synthesis of 3H-spiro[benzofuran-2,1'-cyclohexane] derivatives from naturally occurring filifolinol and their classical complement pathway inhibitory activity.,  16  (19): [PMID:16875818] [10.1016/j.bmcl.2006.07.029]

Source